Patients with preexisting Afib undergoing Coronary Artery Bypass surgery are 64% more likely to experience early mortality. ​​
Surgical ablation changes that trajectory — restoring rhythm, improving survivability and giving patients the quality of life they deserve after surgery.​​

Learn more about the impact of Afib in CABG patients: <a href="https://okt.to/EHosbt&quot; target="_blank">https://okt.to/EHosbt</a&gt; ​

<a href='https://www.linkedin.com/feed/hashtag/?keywords=Afib&highlightedUpdateU…; target='_blank'>#Afib</a> <a href='https://www.linkedin.com/feed/hashtag/?keywords=CABG&highlightedUpdateU…; target='_blank'>#CABG</a> <a href='https://www.linkedin.com/feed/hashtag/?keywords=CardiacSurgery&highligh…; target='_blank'>#CardiacSurgery</a>

With high rates of post-surgical pain, the cryoXT™ probe provides a non-opioid pain management option that manages symptoms at the time of the procedure.​

Discover the latest advancement here: <a href="https://t.co/qciEb5hDrp&quot; target="_blank">https://t.co/qciEb5hDrp</a&gt;

With high rates of post-surgical pain, the cryoXT™ probe provides a non-opioid pain management option that manages symptoms at the time of the procedure.​

Discover the latest advancement here: <a href="https://okt.to/VieQ4S&quot; target="_blank">https://okt.to/VieQ4S</a&gt;

We are looking for a Senior Director, Reimbursement and Market Access based in Minneapolis, MN. This role will lead U.S. reimbursement strategy, payer advocacy and market access initiatives while partnering closely with the Sales, Marketing and Clinical teams. The position also oversees field reimbursement operations and provides strategic guidance to ensure patient access and adoption of our therapies. ​

An excellent opportunity for an experienced leader in reimbursement and health policy to make a meaningful impact. If this sounds like you, we would love to hear from you!

<a href="https://okt.to/o7YOsk&quot; target="_blank">https://okt.to/o7YOsk</a&gt;

Live from <a href="https://twitter.com/hashtag/EACTS2025?src=hashtag_click&quot; target="_blank">#EACTS2025</a>! Visit booth <a href="https://twitter.com/hashtag/2?src=hashtag_click&quot; target="_blank">#2</a> to explore our latest innovations in LAAE and post-op pain management. Experience hands-on training in the Simulation Village and immerse yourself in VR to practice an endoscopic AtriClip PRO•V® placement.

<a href="https://twitter.com/hashtag/LAAExclusion?src=hashtag_click&quot; target="_blank">#LAAExclusion</a> <a href="https://twitter.com/hashtag/CardioTwitter?src=hashtag_click&quot; target="_blank">#CardioTwitter</a>

Live from <a href='https://www.linkedin.com/feed/hashtag/?keywords=EACTS2025&highlightedUp…; target='_blank'>#EACTS2025</a>! Visit booth <a href='https://www.linkedin.com/feed/hashtag/?keywords=2&highlightedUpdateUrns…; target='_blank'>#2</a> to explore our latest innovations in LAAE and post-op pain management. Experience hands-on training in the Simulation Village and immerse yourself in virtual reality (VR) to practice an endoscopic AtriClip PRO•V® placement.

<a href='https://www.linkedin.com/feed/hashtag/?keywords=LAAExclusion&highlighte…; target='_blank'>#LAAExclusion</a> <a href='https://www.linkedin.com/feed/hashtag/?keywords=CardiacSurgery&highligh…; target='_blank'>#CardiacSurgery</a>

The HEAL-IST IDE Trial is underway to evaluate the safety and effectiveness of a new approach called hybrid sinus node sparing ablation in patients with symptomatic IST. ​​Dr. Carlo de Asmundis explains the procedure &amp; trial here: <a href="https://t.co/M5duGQViK6&quot; target="_blank">https://t.co/M5duGQViK6</a&gt;

<a href="https://twitter.com/hashtag/ClinicalTrial?src=hashtag_click&quot; target="_blank">#ClinicalTrial</a> <a href="https://twitter.com/hashtag/IST?src=hashtag_click&quot; target="_blank">#IST</a>

The HEAL-IST Trial is underway to evaluate the safety and effectiveness of a new approach called hybrid sinus node sparing ablation in patients with symptomatic inappropriate sinus tachycardia (IST). ​​​
​
Watch as Dr. Carlo de Asmundis explains the procedure and trial here: <a href="https://okt.to/R0tH3x&quot; target="_blank">https://okt.to/R0tH3x</a&gt; <a href="https://www.facebook.com/hashtag/​

ClinicalTrial" target="_blank">​

#ClinicalTrial</a> <a href="https://www.facebook.com/hashtag/IST&quot; target="_blank">#IST</a> <a href="https://www.facebook.com/hashtag/inappropriatesinustachycardia&quot; target="_blank">#inappropriatesinustachycardia</a>

The HEAL-IST IDE Trial is underway to evaluate the safety and effectiveness of a new approach called hybrid sinus node sparing ablation in patients with symptomatic inappropriate sinus tachycardia (IST). ​​​
​
Dr. Carlo de Asmundis explains the procedure and trial here: <a href="https://okt.to/xZ4Mb5&quot; target="_blank">https://okt.to/xZ4Mb5</a&gt; ​

<a href='https://www.linkedin.com/feed/hashtag/?keywords=ClinicalTrial&highlight…; target='_blank'>#ClinicalTrial</a> <a href='https://www.linkedin.com/feed/hashtag/?keywords=IST&highlightedUpdateUr…; target='_blank'>#IST</a> <a href='https://www.linkedin.com/feed/hashtag/?keywords=inappropriatesinustachy…; target='_blank'>#inappropriatesinustachycardia</a>

The AtriClip PRO-Mini® is designed for increased visualization in minimally invasive procedures for left atrial appendage exclusion.

Learn more about the AtriClip PRO-Mini here: <a href="https://t.co/o8vjUy5nr1&quot; target="_blank">https://t.co/o8vjUy5nr1</a&gt; ​

<a href="https://twitter.com/hashtag/AtriClip?src=hashtag_click&quot; target="_blank">#AtriClip</a> <a href="https://twitter.com/hashtag/LAAE?src=hashtag_click&quot; target="_blank">#LAAE</a>